subhamoy chakraborty retweetledi

New from @triparnasen and colleagues in @CellRepMed:
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer cell.com/cell-reports-m…
@imsubhc @UtsavSen10 @AvisekBanerje11 @astocheva @IcahnMountSinai #lungcancer
English


